Improvement in non-invasive measurements seen after tadalafil in children with PAH

A positive trend in improvement was seen in children with pulmonary arterial hypertension (PAH) treated with tadalafil, according to results of a phase 3 randomized, double-blind placebo-controlled study. In this study, pediatric patients with PAH received tadalafil 20 mg or 40 mg based on their weight (heavy-weight: ≥40 kg; middle-weight:...